Heather Gibson Huddleston

Heather Gibson Huddleston

Auto-generated profile, based on publicly available information

Heather Gibson Huddleston

University of California, San Francisco, San Francisco, California, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
EGEleni A. Greenwood
Eleni A. Greenwood
LPLauri A. Pasch
Lauri A. Pasch
MCMarcelle Ivonne Cedars
Marcelle Ivonne Cedars
RLRichard S. Legro
Richard S. Legro
HHHeather G. Huddleston
Heather G. Huddleston

5 October 2019 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
JRJulie S Rios
Julie S Rios
EGEleni A Greenwood
Eleni A Greenwood
MPMaryEllen Pavone
MaryEllen Pavone
MCMarcelle Ivonne Cedars
Marcelle Ivonne Cedars
RLRichard S Legro
Richard S Legro
HHHeather G Huddleston
Heather G Huddleston
Context The relationship between reproductive and cardiometabolic aging is unclear. It is unknown if the relationship differs across different clinical populations. Objective To determine whether markers of ovarian reserve are associated with cardiometabolic risk in reproductive aged women with unexplained infertility (UI), polycystic ovary syndrome (PCOS), and regularly cycling women (OVA). Design and setting Cross-sectional data from 8 US-based academic centers. Participants Women aged 25–40 from 3 clinical populations: 870 with UI, 640 with PCOS, and 921 community-based OVA. Main Outcome Measures Multivariable linear regression models were used to relate anti-mullerian hormone (AMH) and antral follicle count with cardiometabolic parameters including body mass index (BMI), waist circumference (WC), fasting glucose and insulin, homeostasis model assessment-insulin resistance (HOMA-IR), lipids, and C-reactive protein. Results In age and study site-adjusted models, AMH inversely related to BMI in the UI and OVA groups (P = 0.02 and P < 0.001). Among women with PCOS, AMH inversely related to BMI (P < 0.001), and also to WC (P < 0.001), fasting insulin (P < 0.01), HOMA-IR (P < 0.01), triglycerides (P = 0.04), and C-reactive protein (P < 0.001) and directly related to higher total (P = 0.02), low-density lipoprotein (P < 0.01), and high-density lipoprotein cholesterol (P < 0.01). In OVA, AMH also varied inversely with WC (P < 0.001), fasting insulin (P = 0.02), and HOMA-IR (P = 0.02). Adjustment for BMI eliminated associations in the OVA group but in PCOS, the relationship of AMH to total (P = 0.03) and low-density lipoprotein cholesterol (P = 0.003) remained. Conclusion Associations observed between AMH and cardiometabolic indices are largely explained by BMI in women with and without PCOS. (J Clin Endocrinol Metab XX: 0-0, 2019)

7 September 2025 in Human Reproduction Update
Verified
Journal Article
Open access
MMMalcolm G Munro
Malcolm G Munro
CSChristina A Salazar
Christina A Salazar
BBBala Bhagavath
Bala Bhagavath
MEMark H Emanuel
Mark H Emanuel
HHHeather G Huddleston
Heather G Huddleston
WGWomen's Health Research Collaborative's Endometrial Trauma Group
Women's Health Research Collaborative's Endometrial Trauma Group
BACKGROUND: Reproductive-age women with intrauterine adhesions (IUAs) following uterine surgery may be asymptomatic or may experience light or absent menstruation, infertility, preterm delivery, and/or peripartum hemorrhage. Understanding procedure- and technique-specific risks and the available evidence on the impact of surgical adjuvants is essential to the design of future research. OBJECTIVE AND RATIONALE: While many systematic reviews have been published, most deal with singular aspects of the problem. Consequently, a broadly scoped systematic review and selective meta-analyses identifying evidence strengths and gaps are necessary to inform future research and treatment strategies. SEARCH METHODS: A systematic literature review was performed seeking evidence on IUA incidence following selected uterine procedures and the effectiveness of hysteroscopic adhesiolysis on menstrual, endometrial, fertility, and pregnancy-related outcomes. An evaluation of the impact of surgical adjuvants designed to facilitate adhesion-free endometrial repair was included. Searches were conducted in the PubMed, Embase, and Cochrane databases following PRISMA guidelines and included English-language publications from inception to 8 November 2024. Inclusion criteria restricted articles to those reporting IUA epidemiology or related clinical outcomes. Risk of bias assessment used the US NIH tools for interventional and observational studies. Meta-analyses were conducted and reported only for outcomes where there were sufficient data. Per analysis, we report on proportions (with 95% CI), heterogeneity (I2), and the risk of bias for each study included. OUTCOMES: The review identified 249 appropriate publications. The risks of new-onset IUAs following the removal of products of conception after early pregnancy loss, hysteroscopic myomectomy, and hysteroscopic metroplasty for septum correction were 17% (95% CI: 11–25%; 13 studies, I2 = 87%, poor to good evidence quality), 16% (95% CI: 6–28%; 8 studies, I2 = 93%, fair to good evidence quality), and 28% (95% CI: 13–46%; 8 studies, I2 = 91%, fair to good evidence quality), respectively. For primary IUA prevention with adjuvant intrauterine gel barriers, the relative risks were 0.45 (95% CI: 0.30–0.68; three studies, I2 = 0%, poor to good evidence quality), 0.38 (95% CI: 0.20–0.73; three studies, I2 = 0%, fair evidence quality), and 0.29 (95% CI: 0.12–0.69; three studies, I2 = 0%, fair to good evidence quality), respectively, following the above potentially adhesiogenic procedures. Following adhesiolysis without adjuvants, the IUA recurrence rate was 35% (95% CI: 24–46%; 13 studies, I2 = 95%, poor to good evidence quality), similar to the rate of 43% for both those treated adjuvantly with an intrauterine balloon (95% CI: 35–51%; 14 studies, I2 = 85%, poor to good evidence quality), or an IUD (95% CI: 27–59%; four studies, I2 = 85%, fair to good evidence quality). The recurrence rate for secondary prevention with gel barriers was 28% (95% CI: 4–62%; three studies, I2 = 94%, good evidence quality). Notably, there was an excess rate of associated adverse obstetrical outcomes, including preterm delivery, placenta accreta spectrum, placenta previa, peripartum hemorrhage, and hysterectomy, with evidence demonstrating the beneficial impact of adjuvant therapies on these outcomes. WIDER IMPLICATIONS: This systematic review comprehensively analyzes IUA formation following uterine surgical procedures and adjuvant therapy effectiveness. Even following adhesiolysis, it is apparent that the basilar endometrial trauma thought to facilitate the formation of IUAs may persist and contribute to adverse reproductive outcomes. Many critical gaps remain in our knowledge of the pathogenesis, prevention, and management of endometrial trauma and IUAs. PREGISTRATION NUMBER: PROSPERO (ID: CRD42023366218).

15 February 2024 in F&S Reports
Verified
Journal Article
Open access
HHHeather Gibson Huddleston
Heather Gibson Huddleston
AMAlexander Milani
Alexander Milani
RBRachel Blank
Rachel Blank
To study the impact of polycystic ovary syndrome (PCOS) on work-related impairments and explore relationships with race, mental health, and healthcare delivery indices. A cross-sectional internet-based survey. North American women with PCOS between August 2022 and October 2022. Individuals with a self-reported diagnosis of PCOS. Not applicable. The primary outcome was missed work because of PCOS. The secondary outcomes included leave from work, impacts on the quality of work, and feelings of being held back at work because of PCOS. Of 1,105 respondents, 1,058 reported having PCOS diagnosed by a physician. Of this group, 50.4% reported missing work because of PCOS, 72% felt that PCOS impacted the quality of their work, and 51.5% felt held back at work by PCOS. Multivariate analyses revealed that missing work because of PCOS was independently associated with black race, lack of insurance, requiring multiple doctors for a PCOS diagnosis, needing ≥3 doctors for current care, decreased satisfaction with care, and symptoms of anxiety and depression. Polycystic ovary syndrome significantly impacts employment-related productivity. Factors such as race, mental health, and healthcare delivery appear to play a crucial role in the extent of this impact.

22 December 2023 in F&S Reports
Verified
Journal Article
Open access
AWAnge Wang
Ange Wang
MNMartha Noel
Martha Noel
JCJacob P. Christ
Jacob P. Christ
JCJamie Corley
Jamie Corley
NLNikolaus Lenhart
Nikolaus Lenhart
HHHeather Huddleston
Heather Huddleston
To study the impact of vigorous vs. moderate exercise on metabolic parameters in polycystic ovary syndrome (PCOS). Randomized controlled trial. Unsupervised home-based exercise program. Patients with PCOS on the basis of the Rotterdam criteria with insulin resistance. Participants were block randomized to a home-based exercise program of 75 minutes of vigorous exercise or 150 minutes of moderate exercise per week, for 8 weeks total. Changes in glucose, insulin, and insulin resistance. In total, 36 participants were randomized, of whom 20 completed the study. The percentage changes from baseline at 4 and 8 weeks for fasting glucose, insulin, and homeostatic model assessment for insulin resistance did not significantly differ between the groups, except for the change in the 8-week glucose level, which was more favorable in the moderate arm (8.06% [standard deviation, 6.44%] in the vigorous group compared with −0.32% [standard deviation, 4.91%] in the moderate group). The absolute values of the main outcomes (fasting glucose, insulin, and homeostatic model assessment for insulin resistance) at baseline and 4 and 8 weeks did not significantly differ between trial arms. When assessing the change from baseline at 4 and 8 weeks, overall and within each trial arm, only the 8-week fasting glucose level was significantly greater than the baseline value in the vigorous arm (93.5 [95% confidence interval, 88.7–98.3] vs. 86.8 [95% confidence interval, 81.1–92.4]). Unsupervised short-term exercise programs may not achieve significant metabolic improvements in patients with PCOS, regardless of vigorous vs. moderate intensity. Future studies should investigate this question in larger sample sizes and longer or structured exercise programs. ClinicalTrials.gov identifier, NCT02303470.

1 March 2021 in Fertility and Sterility
Verified
Journal Article
Closed access
XZXiaojie Zhou
Xiaojie Zhou
HHHeather Huddleston
Heather Huddleston